RESUMO
The coexpression of human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins and receptors leads to the lysis of single cells by a process that is dependent upon membrane fusion. This cell lysis was inhibited by low-molecular-weight compounds that interfere with receptor binding or with receptor-induced conformational transitions in the envelope glycoproteins. A peptide, T20, potently inhibited cell-cell fusion but had no effect on single cell lysis mediated by the HIV-1 envelope glycoproteins. Thus, critical events in the lysis of single cells by the HIV-1 envelope glycoproteins occur in intracellular compartments accessible only to small inhibitory compounds.
Assuntos
Éteres/farmacologia , Produtos do Gene env/metabolismo , HIV-1/efeitos dos fármacos , HIV-1/patogenicidade , Hidrocarbonetos Fluorados/farmacologia , Fusão de Membrana/efeitos dos fármacos , Piperazinas/farmacologia , Animais , Linhagem Celular , Efeito Citopatogênico Viral/efeitos dos fármacos , Cães , Enfuvirtida , Proteína gp41 do Envelope de HIV/farmacologia , Humanos , Peso Molecular , Fragmentos de Peptídeos/farmacologiaRESUMO
We report here the adoptive transfer, to patients with metastatic melanoma, of highly selected tumor-reactive T cells directed against overexpressed self-derived differentiation antigens after a nonmyeloablative conditioning regimen. This approach resulted in the persistent clonal repopulation of T cells in those cancer patients, with the transferred cells proliferating in vivo, displaying functional activity, and trafficking to tumor sites. This led to regression of the patients' metastatic melanoma as well as to the onset of autoimmune melanocyte destruction. This approach presents new possibilities for the treatment of patients with cancer as well as patients with human immunodeficiency virus-related acquired immunodeficiency syndrome and other infectious diseases.